rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

Who May Qualify: - Clinician-confirmed diagnosis of PD - Ability to provide willing to sign a consent form, written and verbal - Clinician-diagnosed impulse control disorder or impulse control behaviors including punding/hobbyism and dopamine dysregulation syndrome - A Beck Depression Inventory (BDI) (Beck et al., 1961) score of 14 or lower - A Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) score of 20 or higher - On dopamine-replacement therapy Who Should NOT Join This Trial: - History of seizures or epilepsy - History of brain lesions (such as multiple sclerosis, tumor) reported - History of vascular issues in the brain, such as stroke - History of a moderate to severe traumatic brain injury - Meeting the criteria for a major psychiatric illness such as schizophrenia or depression (BDI score of 14 or higher). - Having significant cognitive impairment (assessed by MoCA, cutoff score of 20) (Nasreddine, et al., 2005) - Having had TMS done in the recent past (within a year) - Pregnancy assessed in female patients - Intracranial metallic objects (except for dental fillings) - Current use of substances or medications known to significantly reduce seizure threshold. Always talk to your doctor about whether this trial is right for you.